B burgdorferi is transmitted by the ticks of the genus ixodes. Ixodes dammini is most frequently implicated in the eastern USA. In the western USA and Japan I paciftcus predominates. I ricinus acts as the vector in Europe with I persulcatus in Asiatic and European Russia. 8 9 The nymphal ticks become infected by B burgdorferi while feeding on small mammals such as the white foot mouse, which act as reservoirs of the spirochaete. The natural hosts of mature ticks are large mammals such as deer. Humans are incidentally bitten when they enter a tick infected area, usually forest or scrub land.'0 Children playing in such areas would be at particular risk of infection. The frequency of infection after a tick bite depends on a number of factors, such as the prevalence ofB burgdorferi infection in the ticks, the duration of tick attachment, and the number of tick bites. In an English study of forestry workers, 25% had serological evidence of B burgdorferi exposure, and 5% symptoms attributable to Lyme disease. ' These workers may have had multiple bites whereas positive Lyme serology was recorded in 20% of Austrian and 7% of Irish populations who reported single bites.'2 13 Another English study reported positive serology in 12% of a population comprising farmers, gamekeepers, and forestry workers. 14 Epidemiology Since 1982 the number of cases of Lyme disease in the USA has increased from 500 to over 4500 in 1988. The highest incidence is in children of less than 15 years and in adults of 25-44 years. '5 Females were infected in 51% of cases. Data on file at the Charing Cross Lyme Disease Reference Laboratory records approximately 600 cases per year or 0-39 cases per 100 000 people. Most seropositivity is detected in middle aged patients, and the number of males is equal to that of females. In the eastern USA most cases occur in the summer months,'0 15 which follows the period of maximal host seeking activity of nymphal ticks in May and June. 16 In the western USA, cases are most common in spring. 5 Bradycardia is not otherwise a feature of the disease. Iritis or panophthalmitis has also been reported, as has isolated inflammation of peripheral muscles. 17 In the third stage, joint disease is most common. As many as 10% of patients may progress to a chronic erosive arthritis.' In an American study of Lyme arthritis in 43 children2' the mean age was 7 8 years and the male:female ratio 7:1. The knee was involved in 41 patients, the elbow in eight, the hip or ankle in four, and the wrist in two. 2' At this stage in older patients demyelinating encephalopathy, polyneuritis, and memory impairment may become manifest.' Acrodermatitis chronica atrophicans is the characteristic skin rash of this phase of the disease. Initially this is a violaceous and often oedematous area of skin in plaques or nodules, which later atrophies. It resembles but is distinct from scleroderma. '7 18 Acrodermatitis is unusual in childhood Lyme borreliosis but at least two cases have been described.22 Eosinophilic fasciitis is a rare complication. 17 As many as 30% of patients do not demonstrate erythema migrans or other signs of early disease before presenting with late complications.23 In European Lyme disease, joint manifestations are reported to be less common than in the USA. Conversely, in Europe nervous involvement tends to be more prominent.2425 In North American Lyme disease, erythema migrans is more often multiple than in Europe. Recent reports suggest that these differences may be less extreme. '3 26 The isolation of B burgdorferi from the blood has raised the possibility of transplacental transfer of the organism. To date, borreliae have been isolated from one stillbirth and one newborn infant but congenital abnormalities Where clinically indicated, specimen testing would have to be repeated. In most instances serum would be a suitable specimen, but if neurological syndromes are being investigated CSF should also be examined. In one study nine patients with neurological syndromes suggestive of Lyme disease had serum which was positive by ELISA, but only one had a CSF positive by ELISA and immunoblot and also evidence of intrathecal antibody production. 3 In interpreting the laboratory results one must be aware that a proportion of the population will have serological evidence of previous exposure to B burgdorferi which may be unrelated to their current symptoms. Seropositivity rates of approximately 25% are detected in high risk populations such as forestry workers or orienteers." 37 Oral doses of tetracycline, 250 mg four times a day, produce peak serum concentrations four times the minimum inhibitor concentration (MIC), whereas phenoxymethylpenicillin in oral doses of 500 mg four times a day produces serum concentrations equal to the MIC.47 Doxycycline in a dosage of 100 mg twice daily may be a convenient alternative. Amoxycillin combined with probenecid has also been used successfully to treat early Lyme disease. A recent study compared amoxycillin and probenecid (500 mg of each three times) to doxycycine (100 mg twice daily). All patients had early skin manifestations of Lyme disease and the duration of therapy was 21 days in each case.48 In all patients the erythema migrans resolved and none developed major late sequelae. Symptoms after treatment such as fatigue, headache and arthralgia, developed in 15% of patients and persisted for up to three months. Such symptoms have been noted by other authors and resolve. They are twice as likely to occur in patients with disseminated early disease than in those with single lesions. 49 The duration of treatment depent n the severity of the illness: 10 days is thougnt to be adequate in mild cases with skin manifestations but 21 days may be more appropriate in cases of disseminated disease. Longer periods of treatment do not reduce the incidence of major or minor late sequelae.49 In children less than 9 years old tetracyclines are contraindicated. In such cases amoxycillin and probenecid orally for 10 to 21 days are the drugs of choice. Erythromycin is a less effective alternative for penicillin sensitive children. In children older than 9 years, oral doxycycline is the most appropriate therapy. Amoxycillin with probenecid is an alternative.
The classical treatment for the neurological signs of Lyme disease was high dose parenteral penicillin.50 In patients who mainfest an uncomplicated Bell's palsy the outcome is usually favourable, and unless symptoms of meningitis or radiculitis are present oral administration is probably adequate. In a Swedish study of doxycycline treatment for neurological Lyme disease, doxycycline concentrations of 0-2 to 1 mg/l were obtained in the CSF during a regimen of 100 mg twice daily, all patients had a favourable outcome.5' On a treatment schedule of 200 mg twice daily, CSF concentrations of 0-6-1 9 mg/l were achieved. The MIC of B burgdorferi was exceeded in the CSF after the first day of this dosage, but three to five days of treatment was needed to achieve comparable levels on the lower dosage regimen. 52 Treatment for patients with meningitis or radiculitis should be more aggressive. Parenteral penicillin in doses of 20 megaunits daily for 10 days has been used as standard treatment for neuroborreliosis. Results have been disappointing and the isolation of B burgdorferi from the CSF of a patient being treated with penicillin underlines the inability of penicillin to kill spirochaetes which may survive under suboptimal conditions.53 From In conclusion, Lyme disease is a serious disorder with potential immediate and long term morbidity and mortality. It occurs in many parts of the world and affects all ages. The diagnosis of Lyme borreliosis should be considered in any unusual neuropathy or arthropathy. Laboratory tests may confirm the diagnosis but must be interpreted with care. Long term complications may occur if it is not recognised and treated effectively. Oral tetracycline, if the patient is older than 9 years, is recommended for early Lyme disease. Younger children should receive amoxycillin and probenecid. In the late stages, ceftriaxone or cefotaxime is more effective than penicillin.
In future, vaccines may provide protection against Lyme borreliosis. Recent evidence in murine models of B burgdorferi: infection suggests that outer membrane proteins may be important in this regard.66
